Added to YB: 2024-03-06
Pitch date: 2024-03-06
EVO [bullish]
Evotec SE
-59.88%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
Market Cap
EUR 1.5B
Pitch Price
EUR 13.03
Price Target
11.30 (+116%)
Dividend
N/A
EV/EBITDA
65.10
P/E
-9.02
EV/Sales
2.21
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Evotec SE's Path to Growth and Valuation Insights
EVO: 80% EBITDA segments, 100% from co-owned. FY30 iPSC €67m EBITDA, 15x = €2.30/sh. Other products €33m EBITDA, 15x = €1.10/sh. Just-Evotec Biologics €288m EBITDA, 17x = €11.30/sh. €11.30 PT.
Read full article (2 min)